本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kalvista Pharmaceuticals Inc

16.01
+0.22001.39%
成交量:188.57万
成交额:3,013.90万
市值:7.97亿
市盈率:-4.33
高:16.20
开:15.75
低:15.59
收:15.79
数据加载中...
2022/10/17

重要事件披露

8-K - Current report
2022/09/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/08

重要事件披露

8-K - Current report
2022/08/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/07

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/07/07

重要事件披露

8-K - Current report
2022/05/27

重要事件披露

8-K - Current report
2022/05/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals